Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Concord Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543960NSE Symbol: CONCORDBIOP/E(TTM):42.09
ISIN Demat:INE338H01029Div & Yield %:0.63EPS(TTM):14.2
Book Value(Rs):99.7123352Market Cap (rupee Cr.):12504.77Face Value(Rs):1
    
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 1055.071200.091016.94853.17712.93616.94
Excise Duty0.000.000.000.000.000.00
Net Sales1055.071200.091016.94853.17712.93616.94
Other Income 52.7344.4533.7835.3123.4213.81
Stock Adjustments 70.6114.7912.0815.6323.9839.05
Total Income1178.411259.331062.80904.11760.33669.80
EXPENDITURE :      
Raw Materials 316.58320.30241.28195.84187.99150.61
Power & Fuel Cost116.20112.23104.9797.6571.6439.86
Employee Cost 170.19138.93123.05110.2895.6969.47
Other Manufacturing Expenses 30.7726.1828.0024.9317.1012.99
Selling and Administration Expenses 100.8899.3191.0882.9367.9044.87
Miscellaneous Expenses 17.2811.098.4613.2022.6610.26
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure751.89708.03596.83524.84462.99328.05
Operating Profit426.53551.29465.97379.27297.34341.74
Interest 0.771.043.185.186.131.05
Gross Profit425.76550.25462.79374.09291.21340.69
Depreciation74.3354.3753.5954.0350.0527.52
Profit Before Tax351.43495.88409.20320.06241.16313.17
Tax86.29118.9699.8379.5358.4975.72
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.873.954.632.404.102.11
Reported Net Profit263.27372.96304.73238.13178.57235.33
Extraordinary Items 22.3527.5010.482.703.865.24
Adjusted Net Profit240.92345.46294.25235.43174.71230.09
Adjst. below Net Profit 55.785.97-0.010.26-0.56-0.04
P & L Balance brought forward1691.001403.601170.33985.51878.02648.43
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 111.9491.5471.4553.5670.525.71
P & L Balance carried down1898.101691.001403.601170.33985.51878.02
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %755.00875.00875.00683.0051.200.00
Earnings Per Share-Unit Curr25.1735.6529.1322.76187.76247.44
Earnings Per Share(Adj)-Unit Curr25.1735.6529.13NANANA
Book Value-Unit Curr193.06173.27145.80123.501164.131051.11